Clinical Trial Update: A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a combination of bempedoic acid, ezetimibe, and a high-intensity statin in patients without cardiovascular events; trial status is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Lipitor (atorvastatin)
• Nexletol (bempedoic acid)
• Zetia (ezetimibe)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Coronary Atherosclerosis, Mixed Dyslipidemia | Phase 3 | Status: NOT_YET_RECRUITING